AFR: BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: BRAIN Biotech AG / Preliminary announcement on the disclosure of financial statements BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] 14.05.2024 / 17:20 CET/CEST Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. BRAIN Biotech AG hereby announces that the following financial reports shall be disclosed: Report Type: Financial report of the group (half-year/Q2) Language: German Date of disclosure: May 28, 2024 Address: https://www.brain-biotech.com/de/investoren/finanzpublikationen/2023-24 Language: English Date of disclosure: May 28, 2024 Address: https://www.brain-biotech.com/investors/financial-publications/2023-24 14.05.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

Language:	English
Company:	BRAIN Biotech AG
	Darmstädter Straße 34-36
	64673 Zwingenberg
	Germany
Internet:	www.brain-biotech.com

End of News	EQS News Service

1903053  14.05.2024 CET/CEST